SCHEMBL18679658

SCHEMBL18679658

Cc1ccc(-c2cc(-c3ccc(-c4c(C)cc(-c5ccc(-n6c7ccccc7c7cc(N(c8ccccc8)c8ccccc8)ccc76)cc5)cc4C)cc3)nc(-c3ccc(C)cc3)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C4 P17516 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
AKR1C1 Q04828 1/20 0.36
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
PTGER4 P35408 1/20 0.34
ALDH1A1 P00352 8/20 0.33
KDM4E B2RXH2 3/20 0.33
MAPT P10636 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
HPGD P15428 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP1B1 Q16678 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
AGTR1 P30556 1/20 0.32
AHR P35869 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18679653 1.00 AKR1C4 (0.36) AKR1C4AKR1C3AKR1C2AKR1C1MEN1
SCHEMBL18679662 0.98 AKR1C4 (0.35) AKR1C4AKR1C3AKR1C2AKR1C1MEN1
SCHEMBL18679765 0.97 PTGER4 (0.34) AKR1C4AKR1C3AKR1C2AKR1C1MEN1
SCHEMBL18679281 0.97 MEN1 (0.36) AKR1C4AKR1C3AKR1C2AKR1C1MEN1
SCHEMBL18679282 0.97 MEN1 (0.36) AKR1C4AKR1C3AKR1C2AKR1C1MEN1
SCHEMBL18679683 0.96 AKR1C4 (0.36) AKR1C4AKR1C3AKR1C2AKR1C1MEN1
SCHEMBL18679767 0.96 AKR1C4 (0.36) AKR1C4AKR1C3AKR1C2AKR1C1MEN1
SCHEMBL18679664 0.96 PTGER4 (0.35) AKR1C4AKR1C3AKR1C2AKR1C1MEN1
SCHEMBL18679646 0.96 PTGER4 (0.35) AKR1C4AKR1C3AKR1C2AKR1C1MEN1
SCHEMBL18684098 0.95 MEN1 (0.34) AKR1C4AKR1C3AKR1C2AKR1C1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200243773-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO LTD (KR) 2020-07-30 US disclosed
US-10651392-B2 Organic light-emitting device SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-05-12 US disclosed
US-20170092872-A1 ORGANIC LIGHT-EMITTING DEVICE PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2017-03-30 US disclosed
US-20170092872-A1 ORGANIC LIGHT-EMITTING DEVICE PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2017-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10651392-B2 Organic light-emitting device OR10J3, L1CAM, EML4 AKR1C4 3359/4885AKR1C3 3039/4885AKR1C2 4138/4885
US-20200243773-A1 ORGANIC LIGHT-EMITTING DEVICE OR10J3, L1CAM, EML4 AKR1C4 3359/4885AKR1C3 3039/4885AKR1C2 4138/4885
US-20170092872-A1 ORGANIC LIGHT-EMITTING DEVICE OR10J3, L1CAM, EML4 AKR1C4 3359/4885AKR1C3 3039/4885AKR1C2 4138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.